プロモーションスケジュール AusCann Group Holdings Ltd
詳細なスケジュール
簡易グラフ
会社について
AusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. さらに詳しく| Industry | Pharmaceuticals |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://auscann.com.au |
| Цена ао | 0.0038 |
| 1日あたりの価格変動: | 0% (0.0038) |
|---|---|
| 週ごとの価格変動: | -38.71% (0.0062) |
| 月ごとの料金変更: | -72.06% (0.0136) |
| 3ヶ月間の価格変動: | -69.6% (0.0125) |
| 半年間の価格変動: | +26.67% (0.003) |
| 年間の価格変動: | +22.58% (0.0031) |
| 3年間の価格推移: | -95.03% (0.0765) |
| 5年間の価格推移: | -98.54% (0.26) |
| 年初からの価格変動: | +137.5% (0.0016) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Christopher Mews A.C.I.S., B. Bus, C.P.A. | Chief Financial Officer | ||
| Ms. Rachel Jelleff Kerr | Company Secretary |
住所: Australia, West Perth, 1202 Hay Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://auscann.com.au
Webサイト: https://auscann.com.au
